Tuesday

TUESDAY, 11 SEPTEMBER, 2007 (Concurrent Sessions WFN & IHA)

Hall 1, Hall 4 and Meeting Room 1

11:00-13:00

Scientific Session V: Experimental Models and HD Therapies in Experimental Models

Chairs:

Anne Rosser (Cardiff, UK), Ethan Signer (New York, USA)

11:00

Rodent Models of HD: a Critical Appraisal
Gillian Bates (London, UK), Blair Leavitt (Vancouver, Canada), Christian Neri (Paris, France), Huu Phuc Nguyen (Tuebingen, Germany)

11:30

Identification of Therapeutic Drugs and Targets Using Drosophila
Larry Marsh (Irvine, USA)

11:50

Developing Inhibitors Of Sirtuin 2 Microtubule Deacetylase for Treatment Aggregate-Asscociated Neurodegenerative Diseases
Aleksey Kazantsev (Charlestown, USA)

12:10

Development of Therapeutic Strategies for HD
Erich Wanker (Berlin, Germany)

12:30

High-Q: Emerging Clinical Candidates from the CHDI Pipeline

12:40

Cysteamine
Sandrine Humbert (Orsay Cedex, France)

12:50

Deep Brain Stimulation in Transgenic Rat Model of Huntington´s Disease
Rinske Vlamings (Maastricht, The Netherlands)

Clinical Session V: HD Related Disorders: Neuroacanthocytosis & HDL2

Chairs:

Ruth Walker (Bronx/NY, USA), Adrian Danek (Munich, Germany)

11:00

Huntington´s Disease-Related Disorders: Introduction and Overview
Ruth Walker (Bronx/NY, USA)

11:15

Huntington´s Disease-Like Disorder 2 (HDL2)
Doda Rudnicki (Baltimore, USA)

11:30

Familiar Acanthozytosis with Paroxysmal Exercise-Induced Dystonia (FAPED)
Alexander Storch (Dresden, Germany)

11:45

McLeod Syndrome: Muscle and Brain
Hans Jung (Zurich, Switzerland)

12:00

Neuropathology of Chorea-Acanthocytosis
Benedikt Bader (Munich, Germany)

12:15

Neuropathology of HD: Do Phenocopies Exist?
Jean-Paul Vonsattel (New York, USA)

12:30

A Database for Neuroacanthocytosis
Adrian Danek (Munich, Germany)

IHA Session V: Challenge of Genetic Information

Chair:

Fiona Richards (Sydney, Australia)

11:00

Identifying, Responding to and Living with the Challenge of Genetic Risk for HD
Claudia Downing (Cambridge, UK)

Open discussion on genetic testing in HD: PGD, PND, Predictive and Diagnostic Testing

Back to Overview